This agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.
Caleb C. McLeod, PharmD
Advertisement
Caleb C. McLeod, PharmD, is a first-year infectious diseases pharmacotherapy fellow at Loma Linda University Medical Center in California. His interests include antimicrobial resistance and antimicrobial stewardship.
Articles by Caleb C. McLeod, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Listeria Outbreak Update: 27 Illnesses and 6 Deaths Linked to Packaged Meals
2
FDA Approves IV Antbiotic, Contepo, for Complicated Urinary Tract Infections
3
FDA Clears Immuron’s IMM-529 For Clinical Testing in C difficile; Phase 2 Set to Begin in Australia
4
Clesrovimab Lowers RSV Hospitalizations and Illness in Healthy Infants
5
